57E-12988-53354
5 vaccinations
7 coded responses
34 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 543 / WI
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
-
2021-03-27
Dose 2 — Pfizer-BioNTech
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-10
- 2021-04-17
-
2021-04-24
Survey response — day 28, dose 2MedDRA: Anxiety, Confusional state, Dyspnoea exertional — Feeling: Good · Be unable to do your normal daily activitiesFree text: Mental anxiety and confusion. Hard to breathe when doing strenuous activities.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-02
- 2021-05-08
- 2021-06-26
-
2021-09-25
Survey response — 6 months, dose 2MedDRA: Brain fog — Feeling: GoodFree text: Brain fogMedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-12-30
-
2022-03-15
Dose 4 — Pfizer-BioNTech
- 2022-03-31
-
2022-09-09
Dose 5 — Pfizer-BioNTech
- 2022-09-30
-
2022-10-07
Survey response — day 28, dose 5MedDRA: Dyspnoea, Insomnia, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activitiesFree text: Sore throat, congestion and hard time sleeping due to hard time breathing.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-14
Survey response — day 35, dose 5MedDRA: Blood glucose fluctuation, Blood glucose increased, COVID-19, Fatigue, Lethargy, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: POSITIVE for COVID-19. Sore throat, congestion, extremely tired and lethargic. Elevated blood sugars and hard to control them(up and down)MedDRA releases: 2024-11 · check-in free text available
-
2022-10-21
Survey response — day 42, dose 5MedDRA: Brain fog, COVID-19, Dizziness, Dyspnoea exertional, Insomnia, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Unevaluable event — Feeling: Good · Be unable to do your normal daily activitiesFree text: Shortness of breath doing simple tasks, dizziness, blood sugar control, brain fog. Trouble sleeping is another one. All of these symptoms are a result of my recovery from COVID-19, which tested positive 10/8/22. I tested negative around 10/17/22.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Survey response — 3 months, dose 5MedDRA: Dyspnoea exertional — Feeling: Good · Be unable to do your normal daily activitiesFree text: Shortness of breath doing simple thingsMedDRA releases: 2024-11 · check-in free text available
-
2023-03-10
Survey response — 6 months, dose 5MedDRA: Dyspnoea — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech | |
| 2 | 2021-03-27 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | Flu |
| 4 | 2022-03-15 | Pfizer-BioNTech | No |
| 5 | 2022-09-09 | Pfizer-BioNTech | No |
Free text
Release 7 — day 28, dose 2
Symptoms: Mental anxiety and confusion. Hard to breathe when doing strenuous activities.
Release 9 — 6 months, dose 2
Symptoms: Brain fog
Release 12 — day 28, dose 5
Symptoms: Sore throat, congestion and hard time sleeping due to hard time breathing.
Release 12 — day 35, dose 5
Symptoms: POSITIVE for COVID-19. Sore throat, congestion, extremely tired and lethargic. Elevated blood sugars and hard to control them(up and down)
Release 12 — day 42, dose 5
Symptoms: Shortness of breath doing simple tasks, dizziness, blood sugar control, brain fog. Trouble sleeping is another one. All of these symptoms are a result of my recovery from COVID-19, which tested positive 10/8/22. I tested negative around 10/17/22.
Release 12 — 3 months, dose 5
Symptoms: Shortness of breath doing simple things
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Blood glucose fluctuation | · | · | ✓ |
| SD | Blood glucose increased | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Confusional state | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release